2Courcoulas AP, Kelly E, Harbrecht BG. Laparoscopic cholecystectomy in the transplant population [J]. Surg Endosc, 1996, 10 ( 5 ) : 516 -519.
二级参考文献9
1Graham SM, Flowers JL, Schweitzer E, et al. The utility of prophylactic laparoscopic cholecystectomy in transplant candidates[J]. Am J Surg,1995,169(1) :44 -49.
2Badalamenti S, Defazio C, Castelnovo C, et al. High prevalence of silent gallstone disease in dialysis patients [ J ] . Nephron, 1994,66(2) :225 -227.
3Greenstein SM, Katz S, Sun S, et al. Prevalence of asymptomatic cholelithiasis and risk of acute cholecystitis after kidney transplantation [ J ] . Transplantation, 1997 , 63 ( 7 ) : 1030 -1032.
4Mareckova O, Skala I, Marecek Z, et al. Bile composition in patients with chronic renal insufficiency [ J ]. Nephrol Dial Transplant, 1990,5 ( 6 ) :423 - 425.
5Villalon I, Tuchweber B, Yousef IM. Effect of a low protein diet on bile flow and composition in rats[ J]. J Nutr,1987,117(4) :678 -683.
6Lethai B, Dumont M, Michel A, et al. Cyclosporine induced cholestasis: inhibition of bile acid secretions caused by the parental molecule [ J ] . Transplant Proc, 1987 , 19 ( 5 ) : 4149 -4151.
7Melvin WS, Meier D J, Elkhammas EA, et al. Prophylactic cholecystectomy is not indicated following renal transplantation[J]. Am J Surg,1998,175(4) :317 -319.
8Sekela ME , Hutchin DA, Young JB, et al. Biliary surgery after cardiac transplantation [ J ] . Arch Surg, 1991 , 126(5) : 571-573.
9Steck TB, Costanzo - nordin MR, Keshavarzian A. Prevalence and management of cholethiasis in heart transplant patients [ J ] .J Heart Lung Transplant, 1991 ,10(6) :1029 - 1032.
5Rostaing L,Nainan G,Rial MD,et al.Switch from a CNI-to a be-latacept-based immunosuppressive regimen in kidney transplant recip-ients is safe and results in better renal function:12 month results from a phaseⅡstudy[J].Am J Transplant,2010,10(Suppl 4):90.
6Marone R,Cmiljanovic V,Giese B,et al.Targeting phosphoinositide3-kinase:moving towards therapy[J].Biochim Biophys Acta,2008,78(4):159-185.
7Takayama T,Umemiya H,Amada H,et al.Pyrrole deriva-tives as potent inhibitors of lymphocyte-specific kinase:structure,synthesis,and SAR[J].Bioorgan Med Chem Lett,2010,20(1):108-111.